17 α-Hydroxyprogesterone caproate (Makena™): in the prevention of preterm birth
{{output}}
17 α-hydroxyprogesterone caproate is a synthetic progestin of which there is now a US FDA-approved formulation available for intramuscular administration (Makena™) to reduce the risk of preterm birth. Intramuscular 17 α-hydroxyprogesterone caproate (identic... ...
